Silver Book Fact

The 5-year survival rate for prostate cancer has increased from 67% to nearly 100% over the past 20 years.

American Cancer Society. Cancer Facts & Figures 2006. Atlanta, GA: American Cancer Society; 2006. http://www.cancer.org/acs/groups/content/@nho/documents/document/caff2006pwsecuredpdf.pdf

Reference

Title
Cancer Facts & Figures 2006
Publisher
American Cancer Society
Publication Date
2006
Authors
American Cancer Society
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • Between August 2004 and July 2014, the FDA approved: Six new anticancer therapeutics Five new uses for previously approved anticancer therapeutics Two new uses for imaging agents One new use for a screening test  
  • Medicines in Devlopment for Cancer, 2008  
  • Following the current path, the prostate cancer incidence rate will increase by 75.4% (786,000) between 2003 and 2023. If an alternative path is taken, there will be 21.5% (393,000) fewer…  
  • The 5-year survival rate for localized breast cancer, is 98%–an 18% increase since the 1950s.